Company Name : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda ISIN Code : EGS381B1C015 Currency : EGP F/S Consolidated Period : From 01/01/2023 To 30/09/2023 Net Profit : 196,978,975 F/S Consolidated Period : From 01/01/2022 To 30/09/2022 Net Comparative Profit : 198,753,022 Audit Status : Reviewed Source : Tenth Of Ramadan Pharmaceutical Industries&Diagnostic-Rameda The Consolidated Financial Statements in Arabic (415 KB) The Consolidated Financial Statements in English (727 KB) The Consolidated Financial Statements in Arabic (415 KB) The Consolidated Financial Statements in English (727 KB)